IL-6 IL-1β IL-8 TNF-α

I. Overview of Cellular Senescence   Cellular senescence is an irreversible growth arrest state entered by normal cells after a limited number of divisions, serving as a safeguard mechanism to control proliferative potential. Senescent cells undergo changes in morphology and metabolic activity; for instance, increased cell volume and upregulation of Senescence-Associated β-galactosidase (SA-β-gal) activity, which becomes a classic detection marker. II. Core Detection Method: SA-β-gal Staining   Principle: The β-galactosidase in the lysosomes of senescent cells is active at pH 6.0 (as opposed to the normal pH 4.0) and can catalyze the substrate X-Gal to produce a blue product. Application: Blue precipitate is observed via optical microscopy. Applicable to cells, frozen sections, and whole-mount tissues. Recommended Products: Special Fixative (Cat# YB2225) Cell Staining Kit (Cat# YB2173) Whole Tissue Staining Kit (Cat# YB2241, includes clearing solution, supports sectioning after whole-mount staining) III. Senescence Markers and Antibody Recommendations According to Cell guidelines, senescence markers are categorized into several classes; combined use is recommended to improve specificity: Cell Cycle Arrest Markers p21 (Cat# YB265313 / YB260038): A p53 downstream CDK inhibitor, key for irreversible arrest. p16INK4a (Cat# YB261143 / YB261605): The most specific senescence marker, consistently upregulated. Negative Proliferation Markers Ki67 (Cat# YB221499 / YB260023): Used to exclude proliferating cells and confirm cycle arrest. PCNA (Cat# YB22010 / YB23010): Decreased expression suggests arrest, while increased levels might indicate DNA damage repair. Nuclear Structure & Chromatin Alterations Lamin B1 (Cat# YB221802 / YB261802): Loss of this nuclear lamina protein leads to loss of nuclear integrity. HMGB1 (Cat# YB26103 / YB22103): Loss of nuclear localization and release into the extracellular space, driving inflammatory senescence. γH2A.X (Cat# YB221841): Marker for DNA double-strand breaks (phosphorylated at Ser139). Senescence-Associated Secretory Phenotype (SASP) IL-6, IL-1β, IL-8, TNF-α (Cat# YB22117 / YB22113, etc.): Pro-inflammatory cytokines that shape a chronic inflammatory microenvironment. p-STAT3 (Cat# YB260001): Key signaling molecule activating SASP and metabolic reprogramming. Metabolism & Oxidative Stress Markers 4-HNE (Cat# YB260073): Lipid peroxidation product whose accumulation drives senescence. MMP3 (Cat# YB26131): Degrades the extracellular matrix and participates in tissue remodeling. IV. Key Experimental Design Points Multiplex Marker Use: Single markers are prone to false positives. A combination is essential, integrating SA-β-gal staining, cell cycle arrest proteins (p16/p21), negative proliferation markers (Ki67), etc., for comprehensive assessment. In Vivo Validation Reference: The text provides a positive control table for senescence assessment in mouse tissues (e.g., p21 expression in aged liver, Lamin B1 reduction in brain tissue), which can guide model selection. Summary Detecting senescent cells requires initial screening via SA-β-gal activity staining, followed by validation using multidimensional markers including cell cycle regulatory proteins, nuclear structural changes, and SASP factors. When selecting antibodies, ensure the catalog numbers match the experimental system (human, mouse, etc.) and detection method (WB, IHC/IF) to guarantee result reliability.